Stockholders' Equity (Tables)

9 Months Ended

May 31, 2022

Share-based Payment Arrangement [Abstract]

Schedule of Recognized Stock-based Compensation Expense

The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions):

	Three months ended				Nine months ended
	May 31, 2022		May 31, 2021		May 31, 2022		May 31, 2021
Restricted stock units	$	13	$	16	$	57	$	68
Employee stock purchase plan	3		3		10		8
Total	$	16	$	19	$	67	$	76

Schedule of Share-based Compensation Information

The following represents the stock-based compensation information as of the period indicated (in millions):

	May 31, 2022
Unrecognized stock-based compensation expense—restricted stock units	$	44
Remaining weighted-average period for restricted stock units expense	1.5 years

Schedule of Common Stock Outstanding

The following represents the common stock outstanding for the periods indicated:

	Three months ended		Nine months ended
	May 31, 2022	May 31, 2021	May 31, 2022	May 31, 2021
Common stock outstanding:
Beginning balances	142,392,135	149,366,501	144,496,077	150,330,358
Shares issued upon exercise of stock options	—	9,321	—	9,321
Shares issued under employee stock purchase plan	1,686	—	522,169	771,548
Vesting of restricted stock	13,609	12,787	2,467,324	2,253,923
Purchases of treasury stock under employee stock plans	(3,766)	(3,436)	(704,040)	(613,715)
Treasury shares purchased(1)	(3,552,475)	(2,547,707)	(7,930,341)	(5,913,969)
Ending balances	138,851,189	146,837,466	138,851,189	146,837,466

(1)In July 2021, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the Company’s common stock (the “2022 Share Repurchase Program”). As of May 31, 2022, 8.6 million shares had been repurchased for $517 million and $483 million remains available under the 2022 Share Repurchase Program.